Yunha Nam

Dr. Yunha Nam


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YNYunha Nam
Yunha Nam
CCChang-Min Choi
Chang-Min Choi
YPYoung Soo Park
Young Soo Park
HJHyunA Jung
HyunA Jung
HHHee Sang Hwang
Hee Sang Hwang
Wonjun JiWonjun Ji
Wonjun Ji
Background: Although early-stage lung cancer has increased owing to the introduction of screening programs, high recurrence rate remains a critical concern. We aimed to explore biomarkers related to the prognosis of surgically resected non-small-cell lung cancer (NSCLC). Methods: In this retrospective study, we collected medical records of patients with NSCLC and matched tissue microarray blocks from surgical specimens. Semiquantitative immunohistochemistry was performed for measuring the expression level of fibroblast activation protein-alpha (FAP-α), Jagged-1 (JAG1), and CUB-domain-containing protein 1 (CDCP1). Results: A total of 453 patients who underwent complete resection between January 2011 and February 2012 were enrolled; 55.2% patients had stage I NSCLC, and 31.1% presented squamous cell carcinoma. Disease stage was a significant risk factor for recurrence and death, and age ≥ 65 years and male sex were associated with poor overall survival. FAP-a and JaG1 were not related to survivals, while CDCP1-expressing patients exhibited poor disease-free and overall survival. Moreover, CDCP1 expression in stage I NSCLC was significantly associated with recurrence. Conclusions: Old age, male sex, and high pathological stage were poor prognostic factors in patients with NSCLC who underwent surgical resection. Furthermore, CDCP1 expression could serve as a biomarker for poor prognosis in stage I NSCLC.

20 December 2024 in Atmosphere
Verified
Journal Article
Open access
PDF file
DHDa Yeon Hwang
Da Yeon Hwang
MAMin-Hyeok An
Min-Hyeok An
PLPureun-Haneul Lee
Pureun-Haneul Lee
JKJung-Hyun Kim
Jung-Hyun Kim
YNYunha Nam
Yunha Nam
AJAn-Soo Jang
An-Soo Jang
Background: The tricellular tight junction protein angulin-1/lipolysis-stimulated lipoprotein receptor (LSR) is linked to numerous signal transduction pathways that govern gene expression, epithelial cell function, and morphogenesis. The effect of titanium dioxide (TiO2) on LSR and asthma remains unknown. The objective of the present study was to evaluate the impact of TiO2 on LSR expression in asthma. Methods: A TiO2-induced animal model of asthma was established using BALB/c mice and cell lines using normal human bronchial epithelial (NHBE) lung cells and we examined LSR, RAGE, and TGFβ expression using this model. Additionally, we analyzed plasma-LSR concentrations and their correlation with clinical variables in asthma patients and control subjects. Results: The LSR concentrations in patients with asthma were lower compared to controls, and were correlated with lung function and inflammatory cell ratio. In NHBE cells treated with Derp1, LSR protein expression was reduced and changed by exposure to TiO2, whereas TGFβ expression was increased and changed. In mouse lungs, LSR expression was significantly reduced in OVA mice and changed in OVA/TiO2 mice. Conclusion: Circulating LSR levels were decreased and correlated with clinical variables in patients with asthma, and they were influenced by TiO2 exposure in mice, suggesting the potential involvement of LSR in asthma pathogenesis.